Borealis Foods Inc. (BRLS): Nasdaq/NYSE listing notice — Borealis Foods receives Nasdaq notice for audit committee non-compliance; cure period until Feb 1, 2026

Borealis Foods Inc.

Nasdaq notified Borealis of non-compliance with Listing Rule 5605(c)(2)(A) for audit committee composition.
Audit Committee had only 2 independent directors after Kanat Mynzhanov resigned from the board.
Company has cure period until the earlier of next annual shareholders' meeting or February 1, 2026.
Notice has no immediate effect on listing of common shares or warrants on Nasdaq.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Borealis Foods Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4), 10A-3).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605(c)(2)(A), 5605(c)(4), 10A-3

Exact text from the filing

August 29, 2025, Borealis Foods Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with the audit committee composition requirement set forth in Nasdaq Listing Rule 5605(c)(2)(A) (the “Nasdaq Composition Requirements”) due to the resignation of Kanat Mynzhanov from the Company’s board of directors (the “Board”). As described in the Company’s Current Report on Form 8-K, which was filed with the SEC on January 6, 2025. Specifically, when the Notice was issued, the

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Borealis Foods Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-084534

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.